SCHEMBL5328997

SCHEMBL5328997

CC(=O)c1cc(C(=O)O)ccc1NS(C)(=O)=O

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NEU3 Q9UQ49 2/20 0.57
ALDH1A1 P00352 3/20 0.50
KMT2A Q03164 2/20 0.50
AKR1C3 P42330 9/20 0.48
AKR1C2 P52895 9/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 2/20 0.48
HSD17B10 Q99714 1/20 0.48
AKR1B10 O60218 1/20 0.47
AKR1B1 P15121 1/20 0.47
AKR1C4 P17516 1/20 0.47
AKR1C1 Q04828 1/20 0.47
HTT P42858 2/20 0.44
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9535456 0.87 AKR1C3 (0.60) ALDH1A1AKR1C3AKR1C2SMN1; SMN2AKR1B10
SCHEMBL567311 0.83 NEU3 (0.63) NEU3ALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL29791247 0.83 NEU3 (0.63) NEU3ALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL5329433 0.80 NEU3 (0.60) NEU3ALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL17973442 0.80 METAP2 (0.51) ALDH1A1KMT2ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6307782 0.80 KDM4E (0.62) NEU3ALDH1A1KMT2AAKR1C3AKR1C2
SCHEMBL3528076 0.79 NEU3 (0.58) NEU3SMN1; SMN2KDM4EHSD17B10HTT
SCHEMBL5322418 0.79 NEU3 (0.58) NEU3ALDH1A1SMN1; SMN2KDM4EHSD17B10
SCHEMBL1285263 0.78 SMN1; SMN2 (0.64) ALDH1A1KMT2AAKR1C3AKR1C2SMN1; SMN2
SCHEMBL7012306 0.78 NEU3 (0.56) NEU3ALDH1A1KMT2AAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007144379-A1 BICYCLIC COMPOUNDS USEFUL AS CATHEPSIN S INBHIBITORS MEDIVIR AB (SE) 2007-12-21 WO disclosed
WO-2007144379-A1 BICYCLIC COMPOUNDS USEFUL AS CATHEPSIN S INBHIBITORS MEDIVIR AB (SE) 2007-12-21 WO disclosed